ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,779,799 | -7.7% | 85,403 | +6.1% | 0.00% | 0.0% |
| Q2 2023 | $1,927,496 | +304.4% | 80,480 | +217.8% | 0.00% | +200.0% |
| Q1 2023 | $476,579 | +13.4% | 25,323 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $420,129 | -2.7% | 26,390 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $432,000 | -88.1% | 26,404 | -64.7% | 0.00% | -87.5% |
| Q2 2020 | $3,628,000 | +23.2% | 74,844 | +7.4% | 0.01% | 0.0% |
| Q1 2020 | $2,945,000 | +9.0% | 69,712 | +10.4% | 0.01% | +33.3% |
| Q4 2019 | $2,702,000 | +495.2% | 63,171 | +379.4% | 0.01% | +500.0% |
| Q1 2017 | $454,000 | -5.4% | 13,178 | -20.8% | 0.00% | 0.0% |
| Q4 2016 | $480,000 | -7.9% | 16,647 | +1.7% | 0.00% | 0.0% |
| Q3 2016 | $521,000 | -58.0% | 16,361 | -57.2% | 0.00% | -66.7% |
| Q2 2016 | $1,240,000 | -44.1% | 38,196 | -51.8% | 0.00% | -40.0% |
| Q1 2016 | $2,218,000 | -5.4% | 79,306 | +20.6% | 0.01% | 0.0% |
| Q4 2015 | $2,344,000 | +5.3% | 65,758 | -2.3% | 0.01% | 0.0% |
| Q3 2015 | $2,225,000 | -18.6% | 67,281 | +3.1% | 0.01% | 0.0% |
| Q2 2015 | $2,732,000 | +27.5% | 65,242 | -0.7% | 0.01% | +25.0% |
| Q1 2015 | $2,142,000 | -1.0% | 65,726 | -3.6% | 0.00% | 0.0% |
| Q4 2014 | $2,164,000 | +27.4% | 68,177 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $1,698,000 | +11.7% | 68,557 | +1.9% | 0.00% | +33.3% |
| Q2 2014 | $1,520,000 | -7.0% | 67,280 | +0.1% | 0.00% | -25.0% |
| Q1 2014 | $1,634,000 | -60.5% | 67,193 | -59.4% | 0.00% | -60.0% |
| Q4 2013 | $4,133,000 | -53.0% | 165,364 | -48.4% | 0.01% | -58.3% |
| Q3 2013 | $8,799,000 | +35.8% | 320,293 | -10.3% | 0.02% | +26.3% |
| Q2 2013 | $6,480,000 | – | 357,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |